UCLA launches clinical trial to help reduce severity of COVID-19 illness in men
LOS ANGELES — UCLA researchers have launched a new clinical trial that uses a hormone suppresser commonly used to treat men with prostate cancer to help improve clinical outcomes for men infected with COVID-19. The phase 2 trial will assess if temporarily suppressing male hormones will reduce the severity of COVID-19 illness by helping patients…
Details